Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Parkinson's disease.

Bobby Thomas1, M Flint Beal

  • 1Department of Neurology and Neuroscience, Weill Medical College of Cornell University, 525 East 68th Street, A-501, New York, NY 10021, USA. bot2003@med.cornell.edu

Human Molecular Genetics
|October 4, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cystathionine γ-lyase is a major regulator of cognitive function through neurotrophin signaling and neurogenesis.

Proceedings of the National Academy of Sciences of the United States of America·2025
Same author

Outcomes of Emergency Department Visits for Urticaria in an Urban Safety-net Hospital Without Allergy-Immunology Consult Service.

The American journal of emergency medicine·2025
Same author

Biliverdin reductase A is a major determinant of protective NRF2 signaling.

Proceedings of the National Academy of Sciences of the United States of America·2025
Same author

Functional analysis of bipartite NRF2 activators that overcome feedback regulation for age-related chronic diseases.

Redox biology·2025
Same author

Intersection of H<sub>2</sub>S and Nrf2 signaling: Therapeutic opportunities for neurodegenerative diseases.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics·2025
Same author

FUNCTIONAL ANALYSIS OF BIPARTITE NRF2 ACTIVATORS THAT OVERCOME FEEDBACK REGULATION FOR AGE-RELATED CHRONIC DISEASES.

bioRxiv : the preprint server for biology·2025
Same journal

Circulating MYOM3 fragments reflect disease severity and therapeutic efficacy in tubular aggregate myopathy and Stormorken syndrome.

Human molecular genetics·2026
Same journal

The FVB-nmd SMARD1 mouse presents with early respiratory deficits and pathology that significantly impact lifespan.

Human molecular genetics·2026
Same journal

Utrophin requires α-Syntrophin to maintain neuromuscular junction integrity in mdx mice.

Human molecular genetics·2026
Same journal

A novel gene ACTRT3 mutations induce sperm malformations and fertilization failure via Acrosomal ultrastructural defects.

Human molecular genetics·2026
Same journal

Nucleic acid-based therapeutic strategies for modulator-refractory cystic fibrosis-causing variants.

Human molecular genetics·2026
Same journal

Evidence that disruption of Discoidin domain receptor 2 contributes to palate malformations through effects on the extracellular matrix.

Human molecular genetics·2026
See all related articles

Parkinson's disease (PD) involves the loss of brain cells. Recent research offers new insights into the molecular mechanisms causing this neurodegeneration, identifying potential pathways for neuroprotective therapies.

Area of Science:

  • Neuroscience
  • Neurodegenerative Diseases
  • Molecular Biology

Background:

  • Parkinson's disease (PD) is a progressive neurodegenerative disorder marked by the loss of dopaminergic neurons, leading to motor symptoms like tremor and rigidity.
  • Current treatments offer symptomatic relief but do not prevent neuronal death, highlighting a critical need for understanding disease pathogenesis.
  • The etiology of PD is complex, involving genetic factors and environmental influences, with sporadic cases being most common.

Purpose of the Study:

  • To review recent findings in Parkinson's disease research.
  • To elucidate molecular mechanisms underlying dopaminergic neuron loss.
  • To identify potential targets for neuroprotective therapies.

Main Methods:

  • Review of recent scientific literature on Parkinson's disease.

Related Experiment Videos

  • Analysis of genetic and environmental factors implicated in PD pathogenesis.
  • Examination of molecular mechanisms including mitochondrial dysfunction and protein aggregation.

    • Main Results:

    • Recent studies implicate mitochondrial dysfunction, oxidative stress, and abnormal protein accumulation/phosphorylation in dopamine neuron degeneration.
    • Genetic discoveries (e.g., alpha-synuclein, parkin, DJ-1, PINK-1, LRRK2) have illuminated molecular pathways in familial PD.
    • These findings provide crucial insights into the pathogenesis of both sporadic and familial forms of PD.

    Conclusions:

    • Understanding the molecular mechanisms of neurodegeneration is key to developing effective therapies for Parkinson's disease.
    • Identification of key molecular players and pathways offers promising targets for neuroprotective interventions.
    • Continued research into cell survival pathways is essential for preventing the progression of this disabling neurological illness.